PMN

MKT CAP:$93M

ProMIS Neurosciences Inc.

Market Cap

$93M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$9.13+$1.99 (+27.87%)

Jun 5, 2026

52W High $28.0052W Low $6.76

Company Details

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, whic...

CEO

—

IPO Date

Jul 17, 2007

Website

www.promisneurosciences.com

Key Metrics TTM (CAD)

Revenue

CAD 0

- YoY

Net Income

-CAD 41M

EPS (Diluted)

Free Cash Flow

-CAD 35M

Revenue / Share

CAD 0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 12, 2026

CAD 0

FY 2025

Mar 25, 2026

CAD 0

Q4 2025

Mar 25, 2026

CAD 0

Q3 2025

Nov 12, 2025

CAD 0

Q2 2025

Aug 13, 2025

CAD 0

Revenue & Profitability (CAD)

Operating Cash Flow (CAD)

CapEx Spend (CAD)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (CAD)

OpEx Breakdown (CAD)

War Chest (CAD)

Shares Outstanding

Revenue Per Employee (CAD)

Revenue / Employee